Alphanox Co.,Ltd. (KOSDAQ:043100)

Market Cap	42.92B
Revenue (ttm)	25.43B
Net Income (ttm)	-6.24B
Shares Out	20.10M
EPS (ttm)	-488.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200,648
Average Volume	1,522,463
Open	1,922.00
Previous Close	1,921.00
Day's Range	1,878.00 - 1,970.00
52-Week Range	1,160.00 - 5,650.00
Beta	0.32
RSI	60.06
Earnings Date	Nov 14, 2025

About Alphanox

Alphanox Co.,Ltd. manufactures and sells medical devices and healthcare products in South Korea. The company offers surgical instruments, trays and containers, and disposable and custom-made devices; spine, trauma, and joint implants; and in vitro diagnostic devices. It also provides direct, dispenser, and portable type hydrogen water generators; medical devices, such as personal and functional devices, dietary supplements, beauty care products, and pillows. The company was formerly known as Solco Biomedical Co., Ltd. and changed its name to Al...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1974
• Employees: 95
• Stock Exchange: KOSDAQ
• Ticker Symbol: 043100

Financial Performance

In 2024, Alphanox's revenue was 26.81 billion, a decrease of -0.26% compared to the previous year's 26.88 billion. Losses were -7.08 billion, -64.89% less than in 2023.